#99 Advanced Lipid Assessment: Laboratory Evaluation & Management

$59.00

Abstract

2.0 CME Total | 0.5 of which is Pharm

LDL Particle size, HDL 1,2,3…, Apo A – B – E, Lipoprotein (a), Fredrickson phenotypes, NMR, VAP and more. In this CE we will break down each of these factors and more as to their testing, meaning, and other things that may aggravate them beyond diet and genomics.

Objectives:

  • Define the biochemical particles assessed in modern lipidology
  • Describe the function of each
  • Differentiate between Fredrickson’s phenotyping (lipoprotein electrophoresis) and NMR
  • Describe risks associated with common patterns
  • Describe serial testing strategies
  • Discuss relevant pharmacology
  • Discuss non-pharmacological interventions
Category:

Description

Abstract

2.0 CME Total | 0.5 of which is Pharm

LDL Particle size, HDL 1,2,3…, Apo A – B – E, Lipoprotein (a), Fredrickson phenotypes, NMR, VAP and more. In this CE we will break down each of these factors and more as to their testing, meaning, and other things that may aggravate them beyond diet and genomics.

Objectives:

  • Define the biochemical particles assessed in modern lipidology
  • Describe the function of each
  • Differentiate between Fredrickson’s phenotyping (lipoprotein electrophoresis) and NMR
  • Describe risks associated with common patterns
  • Describe serial testing strategies
  • Discuss relevant pharmacology
  • Discuss non-pharmacological interventions

There are no reviews yet.

Be the first to review “#99 Advanced Lipid Assessment: Laboratory Evaluation & Management”

Related products